David Williams of The Los Angeles Times has uncovered a $433 million dollar government contract to purchase a smallpox anti-viral drug that may, or may not, be necessary in the case of a bioterrorist attack. For that matter, we are not even sure if the drug will work. ST-246, a pill to be manufactured by Siga Technologies, Inc., would come into play as a second level of defense in the event of a smallpox attack. Currently, the nation has stockpiled some $1 billion in smallpox vaccines, enough to inoculate the entire U.S. population and treat those who have contracted the...
